3 results
To determine whether administration of exogenous surfactant using a minimally-invasive technique improves outcome in preterm infants 25-28 weeks gestation treated with continuous positive airway pressure (CPAP).
Primary objective: To evaluate local implementation, safety, feasibility and efficacy of temporary RV support with the Impella RP circulatory support deviceSecondary objective: -To evaluate the effect of temporary RV support on several clinical and…
To evaluate the efficacy and safety of tucatinib in combination with trastuzumab and pertuzumab as maintenance therapy in subjects with advanced HER2+ breast cancer who have had prior treatment with a taxane, trastuzumab, and pertuzumab.